title: Will Obesity Treatment Reimbursement Benefit Those at Highest Risk?
authors.affiliation: Duke Global Digital Health Science Center, Duke Global Health Institute, Duke University, Durham, NC; Department of Psychology and Neuroscience, Duke University, Durham, NC. Electronic address: gary.bennett@duke.edu.
authors.forename: Gary G
authors.initials: GG
authors.lastname: Bennett
authors.affiliation: Duke Global Digital Health Science Center, Duke Global Health Institute, Duke University, Durham, NC.
authors.forename: Dori M
authors.initials: DM
authors.lastname: Steinberg
authors.affiliation: University of Massachusetts Medical School, Worcester.
authors.forename: Sherry L
authors.initials: SL
authors.lastname: Pagoto
mesh_terms: D015992:Body Mass Index; D003362:Cost-Benefit Analysis; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics* / Q000706:statistics & numerical data; D008297:Male; D008484:Medicaid / Q000191:economics; D006278:Medicare / Q000191:economics; D020380:Needs Assessment; D009765:Obesity / Q000175:diagnosis / Q000191:economics* / Q000628:therapy*; D009767:Obesity, Morbid / Q000175:diagnosis / Q000191:economics / Q000628:therapy; D018570:Risk Assessment; D016896:Treatment Outcome; D014481:United States; D015431:Weight Loss